f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", | | "creator_user_id": "c64e3919-2d1c-42bf-835b-e85a6be9792c", |
| "groups": [], | | "groups": [], |
| "id": "c5b6d62f-c0dc-4179-aa79-79d979db6927", | | "id": "c5b6d62f-c0dc-4179-aa79-79d979db6927", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2023-02-07T07:08:26.589045", | | "metadata_created": "2023-02-07T07:08:26.589045", |
n | "metadata_modified": "2023-02-07T07:45:03.659275", | n | "metadata_modified": "2023-02-07T07:45:27.774976", |
| "name": "malawi-integrated-hiv-program-report-2021-q2", | | "name": "malawi-integrated-hiv-program-report-2021-q2", |
| "notes": "__Program performance highlights by the end of June 2021 | | "notes": "__Program performance highlights by the end of June 2021 |
| include:__\r\n\r\n* Scale-up of integrated HIV services had reached | | include:__\r\n\r\n* Scale-up of integrated HIV services had reached |
t | the following number of sites:\r\n\r\n __727__ static and | t | the following number of sites:\r\n __727__ static and __158__ |
| __158__ outreach HIV testing sites.\r\n __763__ (static) ART | | outreach HIV testing sites.\r\n __763__ (static) ART sites; |
| sites; __609__ of these started at least one pregnant or breastfeeding | | __609__ of these started at least one pregnant or breastfeeding |
| woman.\r\n __699__ sites with HIV-exposed children in | | woman.\r\n __699__ sites with HIV-exposed children in |
| follow-up.\r\n\r\n* __655,092__ persons were tested for HIV by a | | follow-up.\r\n\r\n* __655,092__ persons were tested for HIV by a |
| trained provider and received their results; __125,628 (29%)__ | | trained provider and received their results; __125,628 (29%)__ |
| accessed HIV testing for the first time; __529,427 (81%)__ were repeat | | accessed HIV testing for the first time; __529,427 (81%)__ were repeat |
| testers and __22,876 (4%)__ of these received confirmatory testing | | testers and __22,876 (4%)__ of these received confirmatory testing |
| (after having tested positive in the past). __19,509 (3.1%)__ clients | | (after having tested positive in the past). __19,509 (3.1%)__ clients |
| received a positive result for the first time1.\r\n* A total of | | received a positive result for the first time1.\r\n* A total of |
| __121,505__ people received __201,156__ self-test kits; __91,266 | | __121,505__ people received __201,156__ self-test kits; __91,266 |
| (45%)__ of these were for use by the recipient and 109,890 (55%) for | | (45%)__ of these were for use by the recipient and 109,890 (55%) for |
| onward distribution to sex partners or other people.\r\n* __21,970 | | onward distribution to sex partners or other people.\r\n* __21,970 |
| (98%)__ of __22,424__ blood units collected were screened for (at | | (98%)__ of __22,424__ blood units collected were screened for (at |
| least) HIV, hepatitis B and syphilis.\r\n* A cumulative total of | | least) HIV, hepatitis B and syphilis.\r\n* A cumulative total of |
| __2,777__ clients were referred for PrEP eligibility screening and | | __2,777__ clients were referred for PrEP eligibility screening and |
| __2,120 (93%)__ were found eligible. __1,981 (93%)__ were enrolled on | | __2,120 (93%)__ were found eligible. __1,981 (93%)__ were enrolled on |
| PrEP. __1,711 (87%)__ of all clients ever started were retained on | | PrEP. __1,711 (87%)__ of all clients ever started were retained on |
| PrEP at the end of the quarter.\r\n* __150,647 (97%)__ of __156,053__ | | PrEP at the end of the quarter.\r\n* __150,647 (97%)__ of __156,053__ |
| women at ANC had their HIV status ascertained; __8,603 (6%)__ of these | | women at ANC had their HIV status ascertained; __8,603 (6%)__ of these |
| were HIV positive. __130,346 (95%)__ of __137,419__ at maternity had | | were HIV positive. __130,346 (95%)__ of __137,419__ at maternity had |
| their HIV status ascertained __8,470 (6%)__ of these were HIV | | their HIV status ascertained __8,470 (6%)__ of these were HIV |
| positive.\r\n\u2022 __19,441__ patients started ART this quarter; | | positive.\r\n\u2022 __19,441__ patients started ART this quarter; |
| __79%__ were classified as asymptomatic / in WHO stage 1 and started | | __79%__ were classified as asymptomatic / in WHO stage 1 and started |
| under the \u201cTest & Treat\u201d policy.", | | under the \u201cTest & Treat\u201d policy.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 10, | | "num_tags": 10, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2023-02-07T07:09:29.811839", | | "created": "2023-02-07T07:09:29.811839", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "82243314-52a8-4714-aedc-0224455951ac", | | "id": "82243314-52a8-4714-aedc-0224455951ac", |
| "last_modified": "2023-02-07T07:09:29.770936", | | "last_modified": "2023-02-07T07:09:29.770936", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2021-q2", | | "dha/malawi-integrated-hiv-program-report-2021-q2", |
| "metadata_modified": "2023-02-07T07:09:30.280551", | | "metadata_modified": "2023-02-07T07:09:30.280551", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "Malawi Integrated HIV Program Report 2021 Q2", | | "name": "Malawi Integrated HIV Program Report 2021 Q2", |
| "package_id": "c5b6d62f-c0dc-4179-aa79-79d979db6927", | | "package_id": "c5b6d62f-c0dc-4179-aa79-79d979db6927", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "b5df5bbcb89edae72789ed3bca4aaf9aa1939c7ea80f6cbf85b2b022de6a311f", | | "b5df5bbcb89edae72789ed3bca4aaf9aa1939c7ea80f6cbf85b2b022de6a311f", |
| "size": 4039850, | | "size": 4039850, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 24455951ac/download/malawi_integrated_hiv_program_report_2021-q2.pdf", | | 24455951ac/download/malawi_integrated_hiv_program_report_2021-q2.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "HTC", | | "display_name": "HTC", |
| "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", | | "id": "6a53fcf5-e774-4295-b9c3-32da8b896f9b", |
| "name": "HTC", | | "name": "HTC", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "PMTCT-ART", | | "display_name": "PMTCT-ART", |
| "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", | | "id": "83bf82ef-383c-46e2-a80c-f3431b3f99e2", |
| "name": "PMTCT-ART", | | "name": "PMTCT-ART", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "anc", | | "display_name": "anc", |
| "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", | | "id": "1e47aae6-8e3d-41e7-9b1a-778af0d2f23a", |
| "name": "anc", | | "name": "anc", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "blood safety", | | "display_name": "blood safety", |
| "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", | | "id": "24fd7907-18be-4ad1-80ad-ba65da6a9707", |
| "name": "blood safety", | | "name": "blood safety", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "featured", | | "display_name": "featured", |
| "id": "22f37483-07b1-400c-a6e5-16ff1153a217", | | "id": "22f37483-07b1-400c-a6e5-16ff1153a217", |
| "name": "featured", | | "name": "featured", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "hiv", | | "display_name": "hiv", |
| "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", | | "id": "43013fde-ebf4-470e-9e5d-1a3aa939d404", |
| "name": "hiv", | | "name": "hiv", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "maternity", | | "display_name": "maternity", |
| "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", | | "id": "cd2b6dc5-5d1f-4a03-91da-9a279e193ed2", |
| "name": "maternity", | | "name": "maternity", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "report", | | "display_name": "report", |
| "id": "80c23033-8ff3-483d-8aa6-03e39b117372", | | "id": "80c23033-8ff3-483d-8aa6-03e39b117372", |
| "name": "report", | | "name": "report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "sti", | | "display_name": "sti", |
| "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", | | "id": "38222aa3-73ca-4ca8-8b42-9a5eb558af5a", |
| "name": "sti", | | "name": "sti", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| }, | | }, |
| { | | { |
| "display_name": "viral load", | | "display_name": "viral load", |
| "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", | | "id": "e385a0a4-1722-431f-a657-f9616a14bf6f", |
| "name": "viral load", | | "name": "viral load", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2021 Q2", | | "title": "Malawi Integrated HIV Program Report 2021 Q2", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2021" | | "year": "2021" |
| } | | } |